Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous

NCT07096986 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT07096986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07096986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
November 30, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glomerulonephritis